FDA approves first treatment for frequent urination at night due to overproduction of urine - FDA Press Releases

The U.S. Food and Drug Administration today approved Noctiva (desmopressin acetate) nasal spray for adults who awaken at least two times per night to urinate due to a condition known as nocturnal polyuria (overproduction of urine during the night). Noctiva is the first FDA-approved treatment for this condition.

from Food and Drug Administration--Press Releases http://ift.tt/2lEgCMx
via IFTTT